IDEXX Laboratories, Inc. (IDXX)
NASDAQ: IDXX · Real-Time Price · USD
714.10
-3.37 (-0.47%)
At close: Dec 5, 2025, 4:00 PM EST
710.02
-4.08 (-0.57%)
After-hours: Dec 5, 2025, 5:34 PM EST
IDEXX Laboratories Employees
IDEXX Laboratories had 11,000 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
11,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$378,856
Profits / Employee
$93,402
Market Cap
57.02B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11,000 | 0 | - |
| Dec 31, 2023 | 11,000 | 220 | 2.04% |
| Dec 31, 2022 | 10,780 | 430 | 4.15% |
| Dec 31, 2021 | 10,350 | 1,050 | 11.29% |
| Dec 31, 2020 | 9,300 | 100 | 1.09% |
| Dec 31, 2019 | 9,200 | 823 | 9.82% |
| Dec 31, 2018 | 8,377 | 777 | 10.22% |
| Dec 31, 2017 | 7,600 | 235 | 3.19% |
| Dec 31, 2016 | 7,365 | 565 | 8.31% |
| Dec 31, 2015 | 6,800 | 400 | 6.25% |
| Dec 31, 2014 | 6,400 | 700 | 12.28% |
| Dec 31, 2013 | 5,700 | 300 | 5.56% |
| Dec 31, 2012 | 5,400 | 300 | 5.88% |
| Dec 31, 2011 | 5,100 | 300 | 6.25% |
| Dec 31, 2010 | 4,800 | 0 | - |
| Dec 31, 2009 | 4,800 | 100 | 2.13% |
| Dec 31, 2008 | 4,700 | 0 | - |
| Dec 31, 2007 | 4,700 | 800 | 20.51% |
| Dec 31, 2006 | 3,900 | 600 | 18.18% |
| Dec 31, 2005 | 3,300 | 305 | 10.18% |
| Dec 31, 2004 | 2,995 | 522 | 21.11% |
| Dec 31, 2003 | 2,473 | 292 | 13.39% |
| Dec 31, 2002 | 2,181 | 11 | 0.51% |
| Dec 31, 2001 | 2,170 | -80 | -3.56% |
| Dec 31, 2000 | 2,250 | 200 | 9.76% |
| Dec 31, 1999 | 2,050 | -50 | -2.38% |
| Dec 31, 1998 | 2,100 | 0 | - |
| Dec 31, 1997 | 2,100 | 585 | 38.61% |
| Dec 31, 1996 | 1,515 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IDXX News
- 11 days ago - IDEXX Laboratories Vs ResMed: Which Stock Could Rally? - Forbes
- 23 days ago - Baron Asset Fund Q3 2025 Performance Review - Seeking Alpha
- 4 weeks ago - IDEXX Laboratories: A Strong Third Quarter With Good Future Prospects - Seeking Alpha
- 4 weeks ago - Why Idexx Laboratories Stock Surged by Almost 15% Today - The Motley Fool
- 4 weeks ago - IDEXX Laboratories, Inc. (IDXX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Idexx Stock Pops on Earnings. Pet Health Is Booming. - Barrons
- 4 weeks ago - Idexx Laboratories Extends Rally Following Upbeat Q3 Earnings, Outlook - Benzinga
- 4 weeks ago - IDEXX raises annual forecasts as pet owners spend more on preventive care - Reuters